申请人:Transfusion Health, LLC
公开号:US20220315895A1
公开(公告)日:2022-10-06
This disclosure is directed to, inter alia, methods and systems for preparing oligopotent and unipotent progenitor cells of defined lineages in culture from an expanded source of CD34+ cells, media for making the same, and therapeutic compounds and compositions comprising the same for treatment a variety of diseases included, but not limited to, hematologic disorders, immune diseases, cancers, and infectious diseases.
本公开涉及的是从扩增的CD34+细胞来源中在培养中准备定义谱系的寡能和单能祖细胞的方法和系统,用于制备相应的培养基,以及包含相应的治疗化合物和组合物,用于治疗各种疾病,包括但不限于血液学疾病、免疫性疾病、癌症和传染性疾病。